Literature DB >> 3168690

Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects.

G Baldo-Enzi1, M R Baiocchi, M Grotto, A R Floreani, M Zagolin, M Chiaramonte, F Cera, R Fellin.   

Abstract

Plasma lipids, apoprotein A-I and B in serum and in lipoprotein fractions (VLDL + LDL, HDL2, and HDL3) obtained by preparative ultracentrifugation, as well as postheparin lipoprotein lipase activity (H-TGL and LPL) were evaluated in 17 subjects with primary biliary cirrhosis (stage II and III) subdivided into two groups according to the presence or absence of lipoprotein X (Lp-X). A reduction in total lipoprotein lipase activity was observed in both patient groups, compared to controls (P less than 0.01); the hepatic lipoprotein lipase was significantly reduced (P less than 0.01) only in the Lp-X-positive group. The lipid (477.8 +/- 154.3 vs 239.6 +/- 51.1; P less than 0.01) and protein (147.4 +/- 37.1 vs 83.3 +/- 19.7; P less than 0.01) masses in the VLDL + LDL fraction of the Lp-X-positive group were increased compared to controls. In the same group, the HDL2 fraction also showed an increase in lipid (186.6 +/- 80.0 vs 77.9 +/- 21.6; P less than 0.01) and protein (133.9 +/- 60.0 vs 67.9 +/- 16.5; P less than 0.01) masses; in addition, the HDL2 percent lipid composition was different in the two patient groups, showing a decrease in esterified cholesterol (20.4 +/- 3.6 vs 25.7 +/- 2.2; P less than 0.01) and an increase in phospholipids (59.2 +/- 2.9 vs 54.8 +/- 2.6; p less than 0.01) in the Lp-X-positive group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3168690     DOI: 10.1007/bf01536666

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

Review 1.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

2.  Lecithin--cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice.

Authors:  J Agorastos; C Fox; D S Harry; N McIntyre
Journal:  Clin Sci Mol Med       Date:  1978-04

3.  On the metabolic function of heparin-releasable liver lipase.

Authors:  H Jansen; A van Tol; W C Hülsmann
Journal:  Biochem Biophys Res Commun       Date:  1980-01-15       Impact factor: 3.575

4.  Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis.

Authors:  Y Baruch; J G Brook; S Eidelman; M Aviram
Journal:  Atherosclerosis       Date:  1984-11       Impact factor: 5.162

5.  Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.

Authors:  C E Jahn; E J Schaefer; L A Taam; J H Hoofnagle; F T Lindgren; J J Albers; E A Jones; H B Brewer
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

6.  Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism.

Authors:  J K Huttunen; C Ehnholm; M Kekki; E A Nikkilä
Journal:  Clin Sci Mol Med       Date:  1976-04

7.  Lipoprotein abnormalities in patients with early primary biliary cirrhosis.

Authors:  A Aly; K Carlson; C Johansson; P Kirstein; S Rössner; L Wallentin
Journal:  Eur J Clin Invest       Date:  1984-04       Impact factor: 4.686

8.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

Authors:  L I Gidez; G J Miller; M Burstein; S Slagle; H A Eder
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

9.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

10.  Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles.

Authors:  J S Patton; M C Carey
Journal:  Am J Physiol       Date:  1981-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.